Sympathetic Modulation in Cardiac Arrhythmias: Where We Stand and Where We Go
Journal of Personalized Medicine · 01.05.2023 · 13 (5) · 786
DOI: 10.3390/jpm13050786 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 01.05.2023. Verfasst von Wei-Hsin Chung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Medicine, China Medical University Hospital, Taichung 40447, Taiwan. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taiwan National Science and Technology Council, China Medical University Hospital.
Abstract (Originalsprache)
The nuance of autonomic cardiac control has been studied for more than 400 years, yet little is understood. This review aimed to provide a comprehensive overview of the current understanding, clinical implications, and ongoing studies of cardiac sympathetic modulation and its anti-ventricular arrhythmias’ therapeutic potential. Molecular-level studies and clinical studies were reviewed to elucidate the gaps in knowledge and the possible future directions for these strategies to be translated into the clinical setting. Imbalanced sympathoexcitation and parasympathetic withdrawal destabilize cardiac electrophysiology and confer the development of ventricular arrhythmias. Therefore, the current strategy for rebalancing the autonomic system includes attenuating sympathoexcitation and increasing vagal tone. Multilevel targets of the cardiac neuraxis exist, and some have emerged as promising antiarrhythmic strategies. These interventions include pharmacological blockade, permanent cardiac sympathetic denervation, temporal cardiac sympathetic denervation, etc. The gold standard approach, however, has not been known. Although neuromodulatory strategies have been shown to be highly effective in several acute animal studies with very promising results, the individual and interspecies variation between human autonomic systems limits the progress in this young field. There is, however, still much room to refine the current neuromodulation therapy to meet the unmet need for life-threatening ventricular arrhythmias.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Department of Medicine, China Medical University Hospital, Taichung 40447, Taiwan.
- UCLA Cardiac Arrhythmia Center, Ronald Reagan UCLA Medical Center, Los Angeles, CA 90024, USA.
- School of Medicine, China Medical University, Taichung 404333, Taiwan.
- School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung 404333, Taiwan.
- Department of Chinese Medicine, China Medical University Hospital, Taichung 40447, Taiwan.
ORCID-Profile: Wei-Hsin Chung, Mei-Yao Wu, Kuan-Cheng Chang
Förderung
- Taiwan National Science and Technology Council
- China Medical University Hospital
Zitieren
APA
Chung, W. H., Lin, Y. N., Wu, M. Y., & Chang, K. C. (2023). Sympathetic Modulation in Cardiac Arrhythmias: Where We Stand and Where We Go. Journal of Personalized Medicine, 13(5), 786. https://doi.org/10.3390/jpm13050786
Vancouver
Chung WH, Lin YN, Wu MY, Chang KC. Sympathetic Modulation in Cardiac Arrhythmias: Where We Stand and Where We Go. Journal of Personalized Medicine. 2023;13(5):786. doi:10.3390/jpm13050786
BibTeX
@article{Chung2023,
author = {Chung, Wei-Hsin and Lin, Yen-Nien and Wu, Mei-Yao and Chang, Kuan-Cheng},
title = {Sympathetic Modulation in Cardiac Arrhythmias: Where We Stand and Where We Go},
journal = {Journal of Personalized Medicine},
year = {2023},
volume = {13},
number = {5},
pages = {786},
doi = {10.3390/jpm13050786}
}
EUVIMED